Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure

JAMA

Volumn 295, Issue 9, 2006, Pages 1011-1022

  Imaizumi, Misa ^a,b   Usa, Toshiro ^b   Tominaga, Tan ^c   Neriishi, Kazuo ^a   Akahoshi, Masazumi ^a   Nakashima, Eiji ^a   Ashizawa, Kiyoto ^a   Hida, Ayumi ^a   Soda, Midori ^a   Fujiwara, Saeko ^a   Yamada, Michiko ^a   Ejima, Eri ^b   Yokoyama, Naokata ^d   Okubo, Masamichi ^e   Sugino, Keizo ^f   Suzuki, Gen ^a   Maeda, Renju ^a   Nagataki, Shigenobu ^g   Eguchi, Katsumi ^b  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c SASEBO CHUO HOSPITAL   (Japan)

^d Nagasakiken Saiseikai Hospital   (Japan)

^e Hisayasu Clinic   (Japan)

^f TSUCHIYA GENERAL HOSPITAL   (Japan)

^g Japan Radioisotope Association   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID ANTIBODY;

ADULT; AGED; ARTICLE; ATOMIC BOMB; AUTOIMMUNE DISEASE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; EVALUATION; FEMALE; GRAVES DISEASE; HEALTH SURVEY; HUMAN; HYPOTHYROIDISM; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; STATISTICAL SIGNIFICANCE; THYROID DISEASE; THYROID NODULE;

EID: 33644607312     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.9.1011     Document Type: Article

References (60)

1. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141:259-277.
2. Shore RE, Hildreth N, Dvoretsky P, Andresen E, Moseson M, Pasternack B. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland.AmJ Epidemiol. 1993;137:1068-1080.
3. Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC. Dose-response relationships for radiationinduced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab. 1993;77:362-369.
4. Yoshimoto Y, Ezaki H, Etoh R, Hiraoka T, Akiba S. Prevalence rate of thyroid diseases among autopsy cases of the atomic bomb survivors in Hiroshima, 1951-1985. Radiat Res. 1995;141:278-286.
5. Shore RE, Hildreth N, Dvoretsky P, Pasternack B, Andresen E. Benign thyroid adenomas among persons x-irradiated in infancy for enlarged thymus glands. Radiat Res. 1993;134:217-223.
6. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD Jr. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res. 1989;120:516-531.
7. Pottern LM, Kaplan MM, Larsen PR, et al. Thyroid nodularity after childhood irradiation for lymphoid hyperplasia: a comparison of questionnaire and clinical findings. J Clin Epidemiol. 1990;43:449-460.
8. Shore RE, Moseson M, Harley N, Pasternack BS. Tumors and other diseases following childhood x-ray treatment for ringworm of the scalp (Tinea capitis). Health Phys. 2003;85:404-408.
9. Nagataki S, Hirayu H, Izumi M, Inoue S, Okajima S, Shimaoka K. High prevalence of thyroid nodule in area of radioactive fallout. Lancet. 1989;2:385-386.
10. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature. 1992;359:21.
11. Shibata Y, Yamashita S, Masyakin VB, Panasyuk GD, Nagataki S. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet. 2001;358:1965-1966.
12. Takahashi T, Schoemaker MJ, Trott KR, et al. The relationship of thyroid cancer with radiation exposure from nuclear weapon testing in the Marshall Islands. J Epidemiol. 2003;13:99-107.
13. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab. 1974;38:976-998.
14. Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M, Shimaoka K. Thyroid diseases among atomic bomb survivors in Nagasaki. JAMA. 1994;272:364-370.
15. Kerber RA, Till JE, Simon SL, et al. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA. 1993;270:2076-2082.
16. Pacini F, Vorontsova T, Molinaro E, et al. Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet. 1998;352:763-766.
17. Ito M, Yamashita S, Ashizawa K, et al. Childhood thyroid diseases around Chernobyl evaluated by ultrasound examination and fine needle aspiration cytology. Thyroid. 1995;5:365-368.
18. Takahashi T, Fujimori K, Simon SL, Bechtner G, Edwards R, Trott KR. Thyroid nodules, thyroid function and dietary iodine in the Marshall Islands. Int J Epidemiol. 1999;28:742-749.
19. Eheman CR, Garbe P, Tuttle RM. Autoimmune thyroid disease associated with environmental thyroidal irradiation. Thyroid. 2003;13:453-464.
20. Davis S, Kopecky KJ, Hamilton TE, Onstad L. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford Nuclear Site. JAMA. 2004;292:2600-2613.
21. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors: report 12, part I: cancer: 1950-1990. Radiat Res. 1996;146:1-27.
22. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors: report 12, part II: noncancer mortality: 1950-1990. Radiat Res. 1999;152:374-389.
23. Young RW, Kerr GD, eds. Reassessment of the Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki, Dosimetry System 2002, Report of the Joint US-Japan Working Group. Hiroshima, Japan: Radiation Effects Research Foundation; 2005.
24. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors: part II: solid tumors, 1958-1987. Radiat Res. 1994;137:S17-S67.
25. Akiba S, Lubin J, Ezaki H, et al. Thyroid Cancer Incidence Among Atomic Bomb Survivors, 1958-79. Hiroshima, Japan: Radiation Effects Research Foundation; 1992. Technical Report 5-91.
26. Atomic Bomb Casualty Commission. Research Plan for Joint ABCC-NIH Adult Health Study in Hiroshima and Nagasaki. Hiroshima and Nagasaki, Japan: Atomic Bomb Casualty Commission; 1962. ABCC Technical Report 11-62.
27. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res. 2004;161:622-632.
28. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126:226-231.
29. Soda M, Ikeda T, Matsuo T, Suyama A. Cancer incidence in Nagasaki Prefecture 1993-1997. In: Parkin DM, ed. Cancer Incidence in Five Continents. Vol 8. Lyon, France: International Agency for Research on Cancer/International Association of Cancer Registry; 2003:390-393.
30. Hedinger C, Williams ED, Sobin LH. Histological Typing of Thyroid Tumor. 2nd ed. Berlin, Germany: Springer-Verlag; 1988.
31. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 1989;63:908-911.
32. Preston DL, Pierce DA, Shimizu Y, et al. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res. 2004;162:377-389.
33. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res. 1990;123:275-284.
34. Preston D, Lubin J, Pierce D. Epicure User's Guide. Seattle, Wash: HiroSoft International Corp; 1993.
35. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, eds. Second International Symposium on Information Theory. Budapest, Hungary: Akademiai Kiado; 1973:267-281.
36. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Contr. 1974;AC-19: 716-723.
37. Cox DR, Hinkley DV. Theoretical Statistics. London, England: Chapman & Hall; 1974.
38. Roesch WC, ed. US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki. Hiroshima, Japan: Radiation Effects Research Foundation; 1987.
39. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
40. Fugazzola L, Pilotti S, Pinchera A, et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res. 1995;55:5617-5620.
41. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene. 1995;11:2459-2467.
42. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 1997;57:1690-1694.
43. Williams ED, Abrosimov A, Bogdanova T, et al. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer. 2004;90:2219-2224.
44. Health Expert Group. Health Effects of the Chernobyl Accident and Special Health Care Programes, Working Draft. Geneva, Switzerland: World Health Organization; 2005.
45. Demidchik E, Mrochek A, Demidchik Y, et al. Thyroid cancer promoted by radiation in young people of Belarus (clinical and epidemiological features). Presented at: Radiation and Thyroid Cancer Conference; July 20-23, 1998; Cambridge, England.
46. DeGroot LJ, Reilly M, Pinnameneni K, Refetoff S. Retrospective and prospective study of radiationinduced thyroid disease. Am J Med. 1983;74:852-862.
47. Shore RE, Woodard E, Hildreth N, Dvoretsky P, Hempelmann L, Pasternack B. Thyroid tumors following thymus irradiation. J Natl Cancer Inst. 1985;74:1177-1184.
48. Okamura K, Ueda K, Sone H, et al. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J Am Geriatr Soc. 1989;37:317-322.
49. Vanderpump MPJ, Tunbridge WMG. The epidemiology of thyroid diseases. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000:467-473.
50. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf ). 1991;34:77-83.
51. Fujiwara S, Carter RL, Akiyama M, et al. Autoantibodies and immunoglobulins among atomic bomb survivors. Radiat Res. 1994;137:89-95.
52. Morimoto I, Yoshimoto Y, Sato K, et al. Serum TSH, thyroglobulin, and thyroidal disorders in atomic bomb survivors exposed in youth: 30-year follow-up study. J Nucl Med. 1987;28:1115-1122.
53. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors: report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003;160:381-407.
54. Nygaard B, Faber J, Veje A, Hegedus L, Hansen JM. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Thyroid. 1999;9:477-481.
55. Nygaard B, Knudsen JH, Hegedus L, Scient AV, Hansen JE. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab. 1997;82:2926-2930.
56. Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Horm Metab Res. 2001;33:504-507.
57. Chiovato L, Santini F, Vitti P, Bendinelli G, Pinchera A. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. Clin Endocrinol (Oxf ). 1994;40:803-806.
58. Soule J, Mayfield R. Graves' disease after 131I therapy for toxic nodule. Thyroid. 2001;11:91-92.
59. Davis S, Kopecky KJ, Hamilton TE, et al. Hanford Thyroid Disease Study Final Report. 2002. Available at: http://www.cdc.gov/nceh/radiation/hanford/ htdsweb/. Accessed September 1, 2005.
60. Cologne JB, Preston DL. Longevity of atomic-bomb survivors. Lancet. 2000;356:303-307.